Cano Health, Inc.
CANO · NYSE
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $788,073 | $766,746 | $866,909 | $680,373 |
| % Growth | 2.8% | -11.6% | 27.4% | – |
| Cost of Goods Sold | $772,469 | $826,386 | $776,758 | $573,372 |
| Gross Profit | $15,604 | -$59,640 | $90,151 | $107,001 |
| % Margin | 2% | -7.8% | 10.4% | 15.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $96,473 | $96,587 |
| SG&A Expenses | $80,821 | $99,418 | $96,473 | $107,827 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $11,240 |
| Other Operating Expenses | -$900 | $1,323 | $27,221 | $26,421 |
| Operating Expenses | $107,561 | $188,669 | $123,694 | $134,248 |
| Operating Income | -$466,919 | -$245,634 | -$33,543 | -$26,418 |
| % Margin | -59.2% | -32% | -3.9% | -3.9% |
| Other Income/Exp. Net | -$24,923 | -$26,983 | -$27,042 | -$404,662 |
| Pre-Tax Income | -$491,842 | -$272,617 | -$60,585 | -$300,209 |
| Tax Expense | -$145 | -$1,872 | -$32,435 | $1,516 |
| Net Income | -$260,487 | -$140,753 | -$28,150 | -$301,725 |
| % Margin | -33.1% | -18.4% | -3.2% | -44.3% |
| EPS | -49.35 | -26.67 | -5.59 | -61.7 |
| % Growth | -85% | -377.1% | 90.9% | – |
| EPS Diluted | -49.35 | -26.67 | -5.59 | -61.7 |
| Weighted Avg Shares Out | 5,278 | 5,278 | 5,034 | 4,890 |
| Weighted Avg Shares Out Dil | 5,278 | 5,278 | 5,034 | 4,890 |
| Supplemental Information | – | – | – | – |
| Interest Income | $258 | $90 | $9 | $7 |
| Interest Expense | $29,646 | $26,719 | $23,505 | $19,627 |
| Depreciation & Amortization | $26,740 | $27,252 | $27,662 | $26,421 |
| EBITDA | -$435,456 | -$219,644 | -$9,418 | -$826 |
| % Margin | -55.3% | -28.6% | -1.1% | -0.1% |